News and blogs
433 results found.
Cancer Plan could improve blood cancer survival
New Cancer Plan offers hope of better blood cancer survival, but Blood Cancer UK says funding, staffing and research delivery must match ambition.
Braving daily sea dips for friend with blood cancer
A Guisborough fundraiser takes on daily North Sea swims for Blood Cancer UK, driven by a rugby teammate’s blood cancer diagnosis.
Charities appeal NICE decision on CAR T-cell therapy
Blood Cancer UK, Anthony Nolan and Lymphoma Action have formally appealed against a decision to remove a key CAR T-cell therapy removed as a treatment option for some people with mantle cell lymphoma on the NHS in England and Wales.
Cancer postcode lottery reforms welcome, but blood cancer still at risk of being left out
National charity, Blood Cancer UK has welcomed the government’s commitment to tackling cancer inequalities, while warning that blood cancer must be clearly included in the National Cancer Plan to end long-standing gaps in care.
From Westminster to the ward
Workforce policy in England and its impact on blood cancer
Next generation CAR T-cell therapy offers new hope for people with aggressive blood cancer
NHS England announced a new personalised CAR-T therapy, obe-cel, available within weeks for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia
A new treatment option for people with chronic lymphocytic leukaemia
Drug regulators NICE have approved venetoclax (Venclyxto®) with obinutuzumab for use on the NHS in England.
Living with loss at Christmas
Christmas can be a particularly challenging time of year for anyone dealing with grief. John lost his 23 year old son Tim to blood cancer two decades ago in December. Here he talks about how he's coped in the years since.
Combination treatment improves treatment for people with relapsed myeloma
The study found that people given teclistamab and daratumumab could help people with myeloma whose cancer has come back.
New study strengthens evidence for new CAR T-cell treatment for aggressive blood cancer
The scientists tested a new treatment called BE-CAR7, which uses gene editing to change donor immune cells so they can find and destroy cancer.
New trial shows early signs that ‘off-the-shelf’ CAR T-cell therapy could transform treatment of myeloma
A new trial shows early signs that ‘off-the-shelf’ CAR T-cell therapy could transform treatment of myeloma
Blood Cancer UK funded trial shows survival gain, as experts say drug could be repurposed as new treatment standard for rare blood cancer
A new UK trial has found that an oral treatment called ASTX727, could help people with certain rare blood cancers to live longer.
Blood cancer is Scotland’s third biggest cancer killer taking more than 1,100 lives in a year
Blood Cancer UK’s new manifesto for Scotland, launched ahead of the 2026 Scottish Parliament elections, warns that blood cancer takes over 1,100 lives a year in Scotland. It also warns that 128,000 potential years of life from people in Scotland have been
Blood cancer charity says clinical trials report must be a ‘wake-up call' for government and NHS leader
A new report from the Association of the British Pharmaceutical Industry (ABPI) shows that far fewer people in the UK are being recruited into commercial clinical trials.
Blood cancer experts issue warning about missing data in Wales
Blood Cancer UK’s new manifesto for Wales, launched ahead of the 2026 Senedd elections, warns that Wales is the only UK nation without a government-led cancer plan in existence or development. This risks thousands of people affected by blood cancer being
Funding ideas that breakdown barriers to accessing clinical trials
Discover how our latest funding is helping healthcare professionals improve access and awareness to blood cancer clinical trials.
Blood Cancer UK, one of cancer charities to benefit from Peter Kay’s Final Tour
Peter Kay has announced all profits from his series of final arena shows across the UK will be donated to 12 leading cancer charities, including Blood Cancer UK.
New treatment for aggressive blood cancer now approved on the NHS in England
People living with diffuse large B-cell lymphoma (DLBCL), an aggressive type of blood cancer, who don’t respond to treatment or whose cancer has come back, will soon have access to a new treatment on the NHS.
Welsh school raises nearly £15k for beloved teacher
Pupils, parents, and teachers from West Park Primary School in Porthcawl have raised an incredible £14,713 for Blood Cancer UK, following a sponsored walk held in support of their much-loved teacher, Mr Richard Tunnadine, who has been receiving treatment
You could win a copy of Raymond Briggs' book, The Strange House
By entering our prize draw for free, you could win a copy of The Strange House, the perfect way to gift someone a magic moment this Christmas.
